Literature DB >> 28838925

Case of steroid-responsive encephalopathy from hypoglycaemia.

Jay L Mathur1, Fereshteh Rajabi1, Allison Schroeder2, Torben K Becker3.   

Abstract

Hypoglycaemic encephalopathy is a feared complication in the management of patients with diabetes mellitus. We report on a 73-year-old woman with type 1 diabetes managed with an insulin pump who presented unresponsive after an inappropriate insulin bolus. The patient had minimal improvement in her neurological status over 8 days. After administration of 1 g intravenous methylprednisolone, she had dramatic neurological improvement including successful extubation and discharge from the intensive care unit. Steroid responsive encephalopathy is increasingly recognised in practice and literature. However, to the best of our knowledge, this is the first case of hypoglycaemic encephalopathy that responded to high-dose steroids. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  diabetes; neurological injury; neurology (drugs and medicines)

Mesh:

Substances:

Year:  2017        PMID: 28838925      PMCID: PMC5623988          DOI: 10.1136/bcr-2017-221262

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Steroid-responsive leucoencephalopathy due to cholesterol embolism.

Authors:  Patrice Laloux
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02       Impact factor: 10.154

2.  Predictors of outcome in hypoglycemic encephalopathy.

Authors:  Tetsuhiko Ikeda; Tetsuya Takahashi; Aki Sato; Hajime Tanaka; Shuichi Igarashi; Nobuya Fujita; Takeo Kuwabara; Masato Kanazawa; Masatoyo Nishizawa; Takayoshi Shimohata
Journal:  Diabetes Res Clin Pract       Date:  2013-06-29       Impact factor: 5.602

3.  Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: a case series.

Authors:  Farrah J Mateen; Keith A Josephs; Joseph E Parisi; Daniel A Drubach; Richard J Caselli; Kejal Kantarci; Clifford Jack; Bradley F Boeve
Journal:  Neurocase       Date:  2011-06-30       Impact factor: 0.881

4.  Hypoglycemic encephalopathy.

Authors:  Akira Kuriyama; Kazuaki Sato
Journal:  CMAJ       Date:  2015-07-13       Impact factor: 8.262

5.  Reversible diffusion restriction in the splenium of the corpus callosum due to severe hypoglycemia: A case report and literature review.

Authors:  Halil Onder
Journal:  J Neuroradiol       Date:  2016-08-09       Impact factor: 3.447

6.  Hypoglycaemic encephalopathy.

Authors:  Karim Mahawish
Journal:  BMJ Case Rep       Date:  2016-04-08

Review 7.  MRI and CT appearances in metabolic encephalopathies due to systemic diseases in adults.

Authors:  G Bathla; A N Hegde
Journal:  Clin Radiol       Date:  2012-11-09       Impact factor: 2.350

8.  Patients with type 1 diabetes exhibit altered cerebral metabolism during hypoglycemia.

Authors:  Kim C C van de Ven; Cees J Tack; Arend Heerschap; Marinette van der Graaf; Bastiaan E de Galan
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

9.  Steroid-responsive Hashimoto encephalopathy mimicking Creutzfeldt-Jakob disease.

Authors:  Domenico Santoro; Irene Colombo; Isabella Ghione; Lorenzo Peverelli; Nereo Bresolin; Monica Sciacco; Alessandro Prelle
Journal:  Neurol Sci       Date:  2011-05-10       Impact factor: 3.307

10.  Steroid-responsive encephalopathy associated with autoimmune thyroiditis.

Authors:  Pablo Castillo; Bryan Woodruff; Richard Caselli; Steven Vernino; Claudia Lucchinetti; Jerry Swanson; John Noseworthy; Allen Aksamit; Jonathan Carter; Joseph Sirven; Gene Hunder; Vahab Fatourechi; Bahram Mokri; Daniel Drubach; Sean Pittock; Vanda Lennon; Brad Boeve
Journal:  Arch Neurol       Date:  2006-02
View more
  2 in total

Review 1.  Application of Plasma Exchange in Steroid-Responsive Encephalopathy.

Authors:  Yuting Jiang; Xin Tian; Yixue Gu; Feng Li; Xuefeng Wang
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

2.  Biodistribution of Insulin Following Massive Insulin Subcutaneous Injection.

Authors:  Tomoya Ikeda; Naoto Tani; Tatsuya Hirokawa; Kei Ikeda; Fumiya Morioka; Alissa Shida; Yayoi Aoki; Takaki Ishikawa
Journal:  Intern Med       Date:  2022-03-12       Impact factor: 1.282

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.